FFAR2 and breast carcinoma: In addition, inhibition of Hippo/YAP signaling, upregulation of E-cadherin expression, and prevention of the formation of the invasive phenotype of cancer cells were caused by SCFAs binding to FFAR2 on the surface of breast cancer cells (Thirunavukkarasan et al., 2017).